Related to ViaCord Nabs Rights to TRT’s Platform for Extracting Stem Cells from Cord Tissue

• Intellikine Earns $4M from Infinity on Start of Phase I Trials with PI3K Delta and Gamma
  
• Dedifferentiating Neuronal Progenitors to Stem-Like State Increases Survival In Vivo and Boosts Therapeutic Effects
  
• OGT and Abcodia to Leverage Prospective Biobank for Pancreatic Cancer Diagnostics
  
• Roche and Aileron Pin Third Program to Stapled Peptide Drug Collaboration
  
• Mundipharma Commits $50M to Infinity’s PI3K Inhibitor Program in 2013
  
• Roche, Swiss Academia Establish Translational Research Collaboration
  
• CIRM Okays $27M for Two Funds, Proposes Stem Cell Bank with $30M in Awards
  
• Abbott Pays Reata $400M in Expanded Antioxidant Inflammation Modulator Deal
  
• ViroPharma Pays Meritage Initial $7.5M for Option to Acquire Firm for EoE Drug
  
• Celtaxsys Takes Over Estrellita’s Anti-Inflammation Therapy
  
• Studies Show MSCs Can Deliver shRNAs to Inhibit Huntington Disease Protein
  
• EntreMed Raises $10M To Progress Clinical Anticancer Pipeline and Expand R&D
  
• Telormedix Joins EU-Brazil Consortium Focused on Inflammatory Disorders
  
• VolitionRX to Test Its Cancer Diagnostics Platform with Abcodia’s Biobank
  
• Autologous Mesenchymal Stem Cells Found to Aid Kidney Transplant Function
  
• AlloCure Pockets $25M for Acute Kidney Injury Stem Cell Therapy
  
• AstraZeneca Forges Pact Around Five Amgen Clinical-Stage Anti-Inflammatory mAbs
  
• Celgene Taps AnaptysBio for Therapeutic Antibody Expertise
  
• Newly Identified Brain MSCs Differentiate Along Mesenchymal, Neuronal Lineages
  
• Novo Nordisk, Kennedy Institute Partner on Rheumatoid Arthritis Drug and Biomarker R&D